Arbovax's Series B Round

Arbovax raised a round of funding on December 08, 2010.

Arbovax has a unique technology that modifies arthropod-borne viruses (arboviruses) making them unable to replicate in mammalian cells. Arbovax will leverage this technology through partnerships with …

Articles about Arbovax's Series B Round: